5-90647754-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032119.4(ADGRV1):​c.3279G>T​(p.Leu1093Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 1,609,430 control chromosomes in the GnomAD database, including 366,496 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1093L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.74 ( 42871 hom., cov: 32)
Exomes 𝑓: 0.66 ( 323625 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.293

Publications

40 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.170927E-7).
BP6
Variant 5-90647754-G-T is Benign according to our data. Variant chr5-90647754-G-T is described in ClinVar as Benign. ClinVar VariationId is 46313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.903 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.3279G>T p.Leu1093Phe missense_variant Exon 17 of 90 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.3279G>T p.Leu1093Phe missense_variant Exon 17 of 90 1 NM_032119.4 ENSP00000384582.2 Q8WXG9-1
ADGRV1ENST00000640403.1 linkc.582G>T p.Leu194Phe missense_variant Exon 7 of 29 5 ENSP00000492531.1 A0A1W2PRC7
ADGRV1ENST00000504142.2 linkn.2045G>T non_coding_transcript_exon_variant Exon 11 of 14 5
ADGRV1ENST00000639676.1 linkn.877G>T non_coding_transcript_exon_variant Exon 5 of 11 5

Frequencies

GnomAD3 genomes
AF:
0.741
AC:
112562
AN:
151944
Hom.:
42800
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.910
Gnomad AMI
AF:
0.716
Gnomad AMR
AF:
0.780
Gnomad ASJ
AF:
0.671
Gnomad EAS
AF:
0.812
Gnomad SAS
AF:
0.727
Gnomad FIN
AF:
0.662
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.640
Gnomad OTH
AF:
0.748
GnomAD2 exomes
AF:
0.711
AC:
176353
AN:
247886
AF XY:
0.702
show subpopulations
Gnomad AFR exome
AF:
0.915
Gnomad AMR exome
AF:
0.827
Gnomad ASJ exome
AF:
0.669
Gnomad EAS exome
AF:
0.801
Gnomad FIN exome
AF:
0.670
Gnomad NFE exome
AF:
0.643
Gnomad OTH exome
AF:
0.704
GnomAD4 exome
AF:
0.663
AC:
966248
AN:
1457368
Hom.:
323625
Cov.:
37
AF XY:
0.663
AC XY:
480374
AN XY:
724988
show subpopulations
African (AFR)
AF:
0.916
AC:
30555
AN:
33356
American (AMR)
AF:
0.823
AC:
36712
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.670
AC:
17479
AN:
26084
East Asian (EAS)
AF:
0.817
AC:
32402
AN:
39672
South Asian (SAS)
AF:
0.719
AC:
61847
AN:
86032
European-Finnish (FIN)
AF:
0.668
AC:
35478
AN:
53140
Middle Eastern (MID)
AF:
0.698
AC:
4015
AN:
5756
European-Non Finnish (NFE)
AF:
0.637
AC:
706228
AN:
1108518
Other (OTH)
AF:
0.690
AC:
41532
AN:
60200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
14589
29178
43768
58357
72946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18826
37652
56478
75304
94130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.741
AC:
112688
AN:
152062
Hom.:
42871
Cov.:
32
AF XY:
0.744
AC XY:
55255
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.911
AC:
37802
AN:
41514
American (AMR)
AF:
0.780
AC:
11920
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.671
AC:
2326
AN:
3466
East Asian (EAS)
AF:
0.813
AC:
4200
AN:
5166
South Asian (SAS)
AF:
0.725
AC:
3492
AN:
4818
European-Finnish (FIN)
AF:
0.662
AC:
6981
AN:
10540
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.640
AC:
43524
AN:
67966
Other (OTH)
AF:
0.752
AC:
1588
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1404
2808
4213
5617
7021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.676
Hom.:
154673
Bravo
AF:
0.761
TwinsUK
AF:
0.629
AC:
2332
ALSPAC
AF:
0.649
AC:
2502
ESP6500AA
AF:
0.912
AC:
3338
ESP6500EA
AF:
0.645
AC:
5258
ExAC
AF:
0.709
AC:
85636
Asia WGS
AF:
0.808
AC:
2809
AN:
3478
EpiCase
AF:
0.652
EpiControl
AF:
0.651

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Feb 02, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Caucasian frequency = 4255/6556 (ESP data) -

Jul 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.035
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
13
DANN
Benign
0.29
DEOGEN2
Benign
0.047
T;T;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.17
.;T;T
MetaRNN
Benign
8.2e-7
T;T;T
MetaSVM
Benign
-0.97
T
PhyloP100
0.29
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
2.8
.;N;.
REVEL
Benign
0.061
Sift
Benign
1.0
.;T;.
Sift4G
Benign
1.0
.;T;.
Polyphen
0.0
B;B;.
Vest4
0.028
MutPred
0.52
Gain of catalytic residue at L1093 (P = 0.2302);Gain of catalytic residue at L1093 (P = 0.2302);.;
MPC
0.050
ClinPred
0.00040
T
GERP RS
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.065
gMVP
0.29
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2366777; hg19: chr5-89943571; COSMIC: COSV108245831; API